JSPR FY 2021 Earnings — Jasper Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

JSPRJasper Therapeutics, Inc.

$22M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$37M

Net Income

-$31M

EPS (Diluted)

$-26.89

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$36M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$94M

Total Liabilities

$24M

Stockholders' Equity

$70M

Cash & Equivalents

$85M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$37M	-$21M	-78.1%
Net Income	-$31M	-$32M	+3.3%